Macroview Investment Management’s Zimmer Biomet ZBH Stock Holding History

Macroview Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-120	Closed	-$13K	–	538
2022 Q2	$13K	Hold	120	–	–	0.02%	189
2022 Q1	$15K	Sell	120 -4	-3%	-$482	0.02%	184
2021 Q4	$15K	Hold	124	–	–	0.02%	222
2021 Q3	$18K	Hold	124	–	–	0.02%	131
2021 Q2	$19K	Hold	124	–	–	0.03%	152
2021 Q1	$19K	Hold	124	–	–	0.03%	129
2020 Q4	$18K	Hold	124	–	–	0.03%	124
2020 Q3	$16K	Hold	124	–	–	0.03%	120
2020 Q2	$14K	Hold	124	–	–	0.03%	113
2020 Q1	$12K	Hold	124	–	–	0.03%	117
2019 Q4	$18K	Hold	124	–	–	0.04%	123
2019 Q3	$16K	Hold	124	–	–	0.03%	125
2019 Q2	$14K	Hold	124	–	–	0.04%	131
2019 Q1	$15K	Buy	+124	New	+$14.1K	0.04%	137

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Macroview Investment Management's ZBH Position: Q3 2022 in Review

Macroview Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 120 shares — an estimated $13K sold.

Macroview Investment Management first reported a position in ZBH in Q1 2019 and held it in 14 quarters. The position peaked at $19K in Q2 2021. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Macroview Investment Management reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Macroview Investment Management sold 120 Zimmer Biomet shares in Q3 2022, an estimated $13K.
Macroview Investment Management first reported a position in Zimmer Biomet in Q1 2019 and held it in 14 quarters.
Macroview Investment Management's Zimmer Biomet position peaked at $19K in Q2 2021.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Macroview Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.